502 related articles for article (PubMed ID: 17682002)
21. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut.
Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G
Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427
[TBL] [Abstract][Full Text] [Related]
22. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
Rodrigues M; Zerbini MC; Barbieri D
Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
[TBL] [Abstract][Full Text] [Related]
24. Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.
Prehn JL; Mehdizadeh S; Landers CJ; Luo X; Cha SC; Wei P; Targan SR
Clin Immunol; 2004 Jul; 112(1):66-77. PubMed ID: 15207783
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-deficient mice with colitis.
Matsuda C; Ito T; Song J; Mizushima T; Tamagawa H; Kai Y; Hamanaka Y; Inoue M; Nishida T; Matsuda H; Sawa Y
Clin Exp Immunol; 2007 May; 148(2):348-59. PubMed ID: 17437423
[TBL] [Abstract][Full Text] [Related]
26. Crohn's disease intestinal CD4+ T cells have impaired interleukin-10 production which is not restored by probiotic bacteria.
Hvas CL; Kelsen J; Agnholt J; Höllsberg P; Tvede M; Møller JK; Dahlerup JF
Scand J Gastroenterol; 2007 May; 42(5):592-601. PubMed ID: 17454880
[TBL] [Abstract][Full Text] [Related]
27. Biologic therapy for inflammatory bowel disease.
Ardizzone S; Bianchi Porro G
Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
[TBL] [Abstract][Full Text] [Related]
28. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
29. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
[TBL] [Abstract][Full Text] [Related]
30. Enrichment of IL-17A
Li J; Doty AL; Tang Y; Berrie D; Iqbal A; Tan SA; Clare-Salzler MJ; Wallet SM; Glover SC
Clin Exp Immunol; 2017 Oct; 190(1):143-153. PubMed ID: 28586085
[TBL] [Abstract][Full Text] [Related]
31. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases.
Carrasco A; Fernández-Bañares F; Pedrosa E; Salas A; Loras C; Rosinach M; Aceituno M; Andújar X; Forné M; Zabana Y; Esteve M
J Crohns Colitis; 2016 Sep; 10(9):1042-54. PubMed ID: 26995182
[TBL] [Abstract][Full Text] [Related]
32. Increased Th17-inducing activity of CD14+ CD163 low myeloid cells in intestinal lamina propria of patients with Crohn's disease.
Ogino T; Nishimura J; Barman S; Kayama H; Uematsu S; Okuzaki D; Osawa H; Haraguchi N; Uemura M; Hata T; Takemasa I; Mizushima T; Yamamoto H; Takeda K; Doki Y; Mori M
Gastroenterology; 2013 Dec; 145(6):1380-91.e1. PubMed ID: 23993972
[TBL] [Abstract][Full Text] [Related]
33. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
[TBL] [Abstract][Full Text] [Related]
34. Decreased mucosal interleukin-4 (IL-4) production in gut inflammation.
Karttunnen R; Breese EJ; Walker-Smith JA; MacDonald TT
J Clin Pathol; 1994 Nov; 47(11):1015-8. PubMed ID: 7829675
[TBL] [Abstract][Full Text] [Related]
35. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).
Niessner M; Volk BA
Clin Exp Immunol; 1995 Sep; 101(3):428-35. PubMed ID: 7664489
[TBL] [Abstract][Full Text] [Related]
36. Insight into Crohn's disease pathomorphology.
Mudter J; Neurath MF
Abdom Imaging; 2012 Dec; 37(6):921-6. PubMed ID: 22476334
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of the IL-12 receptor beta 2 chain in Crohn's disease.
Parrello T; Monteleone G; Cucchiara S; Monteleone I; Sebkova L; Doldo P; Luzza F; Pallone F
J Immunol; 2000 Dec; 165(12):7234-9. PubMed ID: 11120856
[TBL] [Abstract][Full Text] [Related]
38. The proportion of Th1 cells, which prevail in gut mucosa, is decreased in inflammatory bowel syndrome.
Van Damme N; De Keyser F; Demetter P; Baeten D; Mielants H; Verbruggen G; Cuvelier C; Veys EM; De Vos M
Clin Exp Immunol; 2001 Sep; 125(3):383-90. PubMed ID: 11531945
[TBL] [Abstract][Full Text] [Related]
39. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
[TBL] [Abstract][Full Text] [Related]
40. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
